Medicine
Cleocin 100 mg vaginal suppository
Cleocin 100 mg vaginal suppository is a prescription medicine containing Clindamycin for vaginal use, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15 – 30°C (59 – 86°F). Caution…
Key facts
- Active ingredient (INN)
- Clindamycin
- Brand
- Cleocin
- Strength
- 100 mg
- Dosage form
- Vaginal suppository
- Route
- Vaginal
- Packs
- 1 blister pack
- Marketing authorisation holder
- Pharmacia & Upjohn
- Manufacturer
- Pharmacia & Upjohn
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15 – 30°C (59 – 86°F). Caution: Avoid heat over 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF01 Clindamycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 February 2024
- Identifiers
- RxCUI 259233, 882533DailyMed set ID 3db26227-208d-4fdd-8426-1d9be5cda9b4NDC 0009-7667Application NDA050767
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 3 suppository in 1 blister pack | 0009-7667-05 | Pharmacia & Upjohn | 3 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 February 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Clindamycin
Clinical summary
Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cleocin Hydrochloride prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Cleocin 100 mg vaginal suppository for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.